Bacterial overgrowth.
Different aspects of bacterial overgrowth in the small intestine are reviewed. The pathophysiological mechanisms involving both bacterial metabolism of dietary components and secretions and effects on the mucosal cells are discussed in more detail. The current therapy, surgical, medical and supportive, is outlined.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004755:Enterobacteriaceae / Q000201:enzymology / Q000254:growth & development* / Q000378:metabolism; D006801:Humans; D007410:Intestinal Diseases / Q000382:microbiology*; D007413:Intestinal Mucosa / Q000648:ultrastructure; D007421:Intestine, Small / Q000378:metabolism / Q000382:microbiology* / Q000503:physiopathology; D008286:Malabsorption Syndromes / Q000209:etiology; D013577:Syndrome
D000900:Anti-Bacterial Agents